| Thomas A Van Dillen, | |
|
1301 Ks Hwy 264, Larned, KS 67550-0089 | |
| (620) 285-4609 | |
| Not Available |
| Full Name | Thomas A Van Dillen |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | 1301 Ks Hwy 264, Larned, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699881458 | NPI | - | NPPES |
| 121002 | Other | KS | CARRIER ASSIGNED |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | T-LP 1377 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas A Van Dillen, 1301 Ks Hwy 264, Larned, KS 67550-0089 Ph: (620) 285-4609 | Thomas A Van Dillen, 1301 Ks Hwy 264, Larned, KS 67550-0089 Ph: (620) 285-4609 |
News Archive
Children who are sexually abused are nearly five times more likely to inject drugs in adulthood as those who are not — while children who witness violence are about three times more likely — according to new research released today at the American Public Health Association's 2016 Annual Meeting and Expo in Denver.
A recent study by researchers at Yale School of Medicine, New York University Langone Health and Washington University School of Medicine, claims that the ketogenic diet (high fat, low carbohydrate diet) is capable of mitigating clinical outcomes of coronavirus disease 2019 (COVID-19) in elderly people by improving immune-metabolic functions and reducing inflammation. The study is currently available on the bioRxiv* preprint server.
A common surgery for non-melanoma skin cancer, known as Mohs surgery typically achieves excellent results but can be a long process, as the surgeon successively removes the area of concern until the surrounding tissue is free of cancer.
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
Eisai Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to its investigational compound (E7777) for cutaneous t-cell lymphoma. E7777 is designed to have an improved purity profile and manufacturing process.
› Verified 3 days ago
Dr. Robin L. Karp, PSYD, L.P. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Highway 264, Larned, KS 67550 Phone: 620-285-4703 | |
Lakshmi Subramanian, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4453 | |
Dr. Rebecca Anne Farr, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Highway 264, Larned, KS 67550 Phone: 620-285-4836 | |
Reba Glidewell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4022 Fax: 620-285-4249 | |
Debra Lynn Vondracek, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4711 | |
John Raeburn Reid, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4065 Fax: 620-285-4249 | |
Christina Eugenia Rudawski, PSY.D Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1301 Ks Hwy 264, Larned, KS 67550 Phone: 620-285-4506 |